CO2021005806A2 - A multi-component composition for use in resolving inflammation - Google Patents

A multi-component composition for use in resolving inflammation

Info

Publication number
CO2021005806A2
CO2021005806A2 CONC2021/0005806A CO2021005806A CO2021005806A2 CO 2021005806 A2 CO2021005806 A2 CO 2021005806A2 CO 2021005806 A CO2021005806 A CO 2021005806A CO 2021005806 A2 CO2021005806 A2 CO 2021005806A2
Authority
CO
Colombia
Prior art keywords
composition
resolution
inflammation
subject
need
Prior art date
Application number
CONC2021/0005806A
Other languages
Spanish (es)
Inventor
Natascha Krömmelbein
Bernd Seilheimer
Original Assignee
Biologische Heilmittel Heel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biologische Heilmittel Heel Gmbh filed Critical Biologische Heilmittel Heel Gmbh
Publication of CO2021005806A2 publication Critical patent/CO2021005806A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una composición para utilizar en la resolución de la inflamación en un sujeto que necesita dicha resolución, en donde dicha composición comprende los siguientes ingredientes: Achillea millefolium, Aconitum napellus, Arnica montana, Atropa bella-donna, Bellis perennis, Calendula officinalis, Echinacea purpurea, Echinacea, Hamamelis virginiana, Hepar sulfuris, Hypericum perforatum, Matricaria recutita, Mercurius solubilis Hahnemanni, y Symphytum officinale. La invención se refiere además a una composición farmacéutica que comprende dicha composición y un fármaco antiinflamatorio. Adicionalmente, la presente invención contempla además un kit para su uso en la resolución de la inflamación en un sujeto que lo necesita, que comprende (i) dicha composición y (ii) un antiinflamatorio.The present invention refers to a composition for use in the resolution of inflammation in a subject in need of such resolution, wherein said composition comprises the following ingredients: Achillea millefolium, Aconitum napellus, Arnica montana, Atropa bella-donna, Bellis perennis, Calendula officinalis, Echinacea purpurea, Echinacea, Hamamelis virginiana, Hepar sulfuris, Hypericum perforatum, Matricaria recutita, Mercurius solubilis Hahnemanni, and Symphytum officinale. The invention further relates to a pharmaceutical composition comprising said composition and an anti-inflammatory drug. Additionally, the present invention further contemplates a kit for use in the resolution of inflammation in a subject in need, comprising (i) said composition and (ii) an anti-inflammatory.

CONC2021/0005806A 2018-10-30 2021-04-30 A multi-component composition for use in resolving inflammation CO2021005806A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18203424 2018-10-30
PCT/EP2019/079486 WO2020089205A1 (en) 2018-10-30 2019-10-29 A multi-component composition for use in resolving inflammation

Publications (1)

Publication Number Publication Date
CO2021005806A2 true CO2021005806A2 (en) 2021-07-30

Family

ID=64048788

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2021/0005806A CO2021005806A2 (en) 2018-10-30 2021-04-30 A multi-component composition for use in resolving inflammation

Country Status (3)

Country Link
EP (1) EP3873507A1 (en)
CO (1) CO2021005806A2 (en)
WO (1) WO2020089205A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229648B2 (en) * 2003-03-14 2007-06-12 Dreyer Lee R Homeopathic formulations useful for treating pain and/or inflammation
WO2009047005A2 (en) * 2007-10-10 2009-04-16 Daniel Farrington A homeopathic complex
RU2476232C1 (en) * 2011-11-25 2013-02-27 Леонид Владимирович Космодемьянский Dr lvkosmodemyanskiy's homeopathic compositions for treating and preventing inflammatory digestive diseases and complications thereof, as well as methods for using them
US20170290873A1 (en) * 2016-04-08 2017-10-12 Stellalife Method Of Using Homeopathic Kit Containing Gel, Rinse And Spray For Management Of Post-Oral Surgical Recovery And Maintenance Of Oral Health

Also Published As

Publication number Publication date
EP3873507A1 (en) 2021-09-08
WO2020089205A1 (en) 2020-05-07

Similar Documents

Publication Publication Date Title
CY1121949T1 (en) PHARMACEUTICAL FORMS OF ANTI-EGFR ANTIBODY-DRUG CONJUGATE
MX2022012536A (en) Compositions comprising sulfated polysaccharides.
PE20181805A1 (en) COMPOSITIONS AND ANTI-TIM-3 ANTIBODIES
CL2018003438A1 (en) Alpha-synuclein antibodies and uses thereof.
ES2540747T3 (en) Topical anti-inflammatory combination
BR112018011152A2 (en) controlled-release cnp agonists with increased nep stability
CL2008000094A1 (en) COMPOUNDS DERIVED FROM PTERIDINE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO INCREASE VASODILATATION.
CL2011000230A1 (en) Isolated human monoclonal antibody that binds to the tissue factor pathway inhibitor (tfpi); pharmaceutical composition that includes it; use to treat acquired or genetic deficiencies of coagulation, or to shorten bleeding time.
CL2007003685A1 (en) COMPOUNDS DERIVED FROM INDOL WITH A UNITED RING IN POSITIONS 4 AND 5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A VIRAL INFECTION.
CL2008001467A1 (en) Cylcr4 antagonist cylindrical peptides cycled by lactams: pharmaceutical composition comprising them; and its use to treat rheumatic arthritis, pulmonary fibrosis, hiv infection or cancer.
AR057181A1 (en) NEW COMBINATION DOSAGE FORM
CL2007001665A1 (en) Antibody or fragment thereof with neutralizing activity of protein nr 10; agent who understands it; and its use to prevent or treat an inflammatory disease.
CL2007003684A1 (en) COMPOUNDS DERIVED FROM INDOL WITH A UNITED RING IN POSITIONS 5 AND 6; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A VIRAL INFECTION.
CL2008003241A1 (en) Binding molecule comprising an antigen-binding portion that binds to a c3b neoepitope; pharmaceutical composition comprising it; and its use to treat eye disorders
BRPI0716495A2 (en) (R, R) - PHENOTEROL AND (R, R) - OR (R, S) - PHENOTEROL ANALOGUE, USE OF THE SAME IN THE PREPARATION OF PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL COMPOSITION UNDERSTANDING SUCH COMPOUNDS.
CL2008001835A1 (en) Use of polycyclic guanine derived compounds to treat inflammation; guanine derived compounds; and pharmaceutical composition that includes them.
CL2011003144A1 (en) Crystalline form e3 of atazanavir bisulfate; pharmaceutical composition comprising it; Useful for the treatment of diseases caused by retroviruses (divisional of the application 1057-05).
CL2022002247A1 (en) Heavy chain antibodies that bind cd22 (application divisional 202001703)
RU2010134766A (en) COMPOSITIONS FOR TREATING Benign Hypertrophy of Prostate, Prostatitis, Prostatosis, and Prostate Cancer
CO2021005806A2 (en) A multi-component composition for use in resolving inflammation
CO2021013244A2 (en) Aqueous pharmaceutical composition of anti-il17a antibody and its use
CO2023000679A2 (en) brm antibody-conjugated chemical degradation inducers and methods thereof
AR117652A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING CONJUGATES OF ANTI-191P4D12 ANTIBODY AND DRUG AND METHODS OF USING THEM
CL2012003119A1 (en) Pharmaceutical composition for injection that compensates for an aqueous solution of ibuprofen and trometamol, in which the concentration of ibuprofen is between 2 and 6 mg / ml, the concentration of trometamol is between 1.8 and 5.8 mg / ml, and the pH is between 7.0 and 9.5; and its use for the treatment of pain, inflammation or fever.
ATE541855T1 (en) OTHER CRYSTALLINE FORMS OF ROSTAFUROXIN